Acceptability and feasibility of S-1 plus cisplatin adjuvant chemotherapy for completely resected non-small cell lung cancer: an open-label, single arm, multicenter, phase 2 trial

le Uematsu, Shugo, Sano, Atsushi, Isobe, Kazutoshi, Usui, Kazuhiro, Matsumoto, Jun, Kiribayashi, Takaharu, Obara, Kiyohaya, Kitami, Akihiko, Murakami, Yoshitaka, Iyoda, Akira
Foilsithe in J Thorac Dis (2021)

Neutrophil/lymphocyte ratio has a prognostic value for patients with terminal cancer

le Nakamura, Yoichi, Watanabe, Ryohei, Katagiri, Miwa, Saida, Yoshihisa, Katada, Natsuya, Watanabe, Manabu, Okamoto, Yasushi, Asai, Koji, Enomoto, Toshiyuki, Kiribayashi, Takaharu, Kusachi, Shinya
Foilsithe in World J Surg Oncol (2016)

Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled t...

le Hata, Yoshinobu, Kiribayashi, Takaharu, Kishi, Kazuma, Nagashima, Makoto, Nakayama, Takefumi, Ikeda, Shingo, Kadokura, Mitsutaka, Ozeki, Yuichi, Otsuka, Hajime, Murakami, Yoshitaka, Takagi, Keigo, Iyoda, Akira
Foilsithe in BMC Cancer (2017)